In this study, we performed a thorough explorative analysis of EGFR-positive NSCLC through NGS profiling of the plasma sample collected upon disease progression of 124 patients in order to characterize the molecular mechanisms via which tumors may progress and to identify the molecular mechanisms underlying different prognoses. Here, EGFR is linked to non-small cell lung carcinoma.